{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T15:01:00Z","timestamp":1781276460651,"version":"3.54.1"},"reference-count":27,"publisher":"BMJ","issue":"11","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2021,8,16]]},"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Graves\u2019 disease (GD) can both aggravate pre-existing cardiac disease and cause de novo heart failure (HF), but large-scale studies are lacking. We aimed to investigate the incidence, risk factors and outcomes of incident GD-related HF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with GD (2009\u20132019) were retrospectively included. HF with reduced ejection fraction (HFrEF) was defined by left ventricular ejection fraction &lt;50%\u2009and Framingham criteria, while HF with preserved ejection fraction (HFpEF) was defined according to the HFA-PEFF criteria. HF due to ischaemia, valve disorder or other structural heart disease was excluded. Proportional hazards regression was used to analyse risk factors and outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 1371 patients with GD, HF occurred in 74 (5.4%) patients (31 (2.3%) HFrEF; 43 (3.1%) HFpEF). In HFrEF, atrial fibrillation (AF) (HR 10.5 (3.0\u201337.3), p&lt;0.001) and thyrotropin receptor antibody (TRAb) level (HR 1.05 (1.01\u20131.09) per unit, p=0.007) were independent risk factors. In HFpEF, the independent risk factors were chronic obstructive pulmonary disease (HR 7.2 (3.5\u201314.6), p&lt;0.001), older age (HR 1.5 (1.2\u20132.0) per 10 years, p=0.001), overt hyperthyroidism (HR 6.4 (1.5\u201327.1), p=0.01), higher body mass index (BMI) (HR 1.07 (1.03\u20131.10) per unit, p=0.001) and hypertension (HR 3.1 (1.3\u20137.2), p=0.008). The risk of cardiovascular hospitalisations was higher in both HFrEF (HR 10.3 (5.5\u201319.4), p&lt;0.001) and HFpEF (HR 6.7 (3.7\u201312.2), p&lt;0.001). However, only HFrEF was associated with an increased risk of all-cause mortality (HR 5.17 (1.3\u201319.9), p=0.02) and ventricular tachycardia\/fibrillation (HR 64.3 (15.9\u2013259.7), p&lt;0.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>De novo HF occurs in 5.4% of patients with GD and is associated with increased risk of cardiovascular hospitalisations and mortality. Risk factors include AF, higher TRAb, higher BMI and overt hyperthyroidism.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/heartjnl-2021-319752","type":"journal-article","created":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T13:49:32Z","timestamp":1630936172000},"page":"868-874","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":12,"title":["Incidence, risk factors, natural history and outcomes of heart failure in patients with Graves\u2019 disease"],"prefix":"10.1136","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6210-7669","authenticated-orcid":false,"given":"Jwan A","family":"Naser","sequence":"first","affiliation":[{"name":"Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorin","family":"Pislaru","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius N","family":"Stan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,9,6]]},"reference":[{"key":"2026061207301422000_108.11.868.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200102153440707"},{"key":"2026061207301422000_108.11.868.2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112488"},{"key":"2026061207301422000_108.11.868.3","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2010.105"},{"key":"2026061207301422000_108.11.868.4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.12.4701"},{"key":"2026061207301422000_108.11.868.5","first-page":"50","article-title":"Thyrotoxicosis and the heart--a review of the literature","volume":"10","author":"Kolawole","year":"2001","journal-title":"Niger J Med"},{"key":"2026061207301422000_108.11.868.6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2011.03981.x"},{"key":"2026061207301422000_108.11.868.7","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(49)90883-2"},{"key":"2026061207301422000_108.11.868.8","first-page":"296","article-title":"Effects of thyroid hormones on the heart","volume":"26","author":"Vargas-Uricoechea","year":"2014","journal-title":"Clin Investig Arterioscler"},{"key":"2026061207301422000_108.11.868.9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.14797\/mdcj-13-2-60","article-title":"Hyperthyroidism and the heart","volume":"13","author":"Osuna","year":"2017","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"2026061207301422000_108.11.868.10","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-12-0627"},{"key":"2026061207301422000_108.11.868.11","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1089\/thy.2017.0461","article-title":"Cardiovascular morbidity and mortality after treatment of hyperthyroidism with either radioactive iodine or thyroidectomy","volume":"28","author":"Ry\u00f6di","year":"2018","journal-title":"Thyroid"},{"key":"2026061207301422000_108.11.868.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.08.042"},{"key":"2026061207301422000_108.11.868.13","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0229"},{"key":"2026061207301422000_108.11.868.14","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1056\/NEJM198211043071901","article-title":"Abnormal left ventricular function in hyperthyroidism: evidence for a possible reversible cardiomyopathy","volume":"307","author":"Forfar","year":"1982","journal-title":"N Engl J Med"},{"key":"2026061207301422000_108.11.868.15","first-page":"38","article-title":"Cor thyreotoxicum. Part I-new findings about its etiopathogenesis and diagnosis","volume":"48","author":"Hrnciar","year":"2002","journal-title":"Overview of problems based on 35 years' experience]. Vnitr Lek"},{"key":"2026061207301422000_108.11.868.16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3949\/ccjm.70.1.57","article-title":"Thyrotoxicosis and the cardiovascular system: subtle but serious effects","volume":"70","author":"Roffi","year":"2003","journal-title":"Cleve Clin J Med"},{"key":"2026061207301422000_108.11.868.17","doi-asserted-by":"crossref","unstructured":"Albakri A . Thyrotoxic heart failure: a review of clinical status and meta-analysis of electrocardiogram diagnosis and medical clinical management methods. Integr Mol Med 2018;5.doi:10.15761\/IMM.1000350","DOI":"10.15761\/IMM.1000350"},{"key":"2026061207301422000_108.11.868.18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2143\/AC.61.1.2005149","article-title":"Cardiomyopathy and thyrotoxicosis: tachycardiomyopathy or thyrotoxic cardiomyopathy?","volume":"61","author":"Vydt","year":"2006","journal-title":"Acta Cardiol"},{"key":"2026061207301422000_108.11.868.19","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.98.21.2282"},{"key":"2026061207301422000_108.11.868.20","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1093\/eurheartj\/ehz641","article-title":"How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)","volume":"40","author":"Pieske","year":"2019","journal-title":"Eur Heart J"},{"key":"2026061207301422000_108.11.868.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2016.01.011"},{"key":"2026061207301422000_108.11.868.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32520-5"},{"key":"2026061207301422000_108.11.868.23","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.025941"},{"key":"2026061207301422000_108.11.868.24","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2006.100628"},{"key":"2026061207301422000_108.11.868.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2009.04.022"},{"key":"2026061207301422000_108.11.868.26","doi-asserted-by":"publisher","DOI":"10.1210\/en.2010-0424"},{"key":"2026061207301422000_108.11.868.27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/452709","article-title":"Determinants of thyrotoxic cardiomyopathy recovery","volume":"2013","author":"Oliveros-Ruiz","year":"2013","journal-title":"Biomed Res Int"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2021-319752","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T14:31:32Z","timestamp":1781274692000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2021-319752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,6]]},"references-count":27,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,5,12]]},"published-print":{"date-parts":[[2022,6]]}},"alternative-id":["10.1136\/heartjnl-2021-319752"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2021-319752","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,6]]}}}